Triazine angiogenesis inhibitors
US6150362A · kind A · utility
13Cited by
11References
3Claims
0Family size
Inventors
Key dates
| Filing date | Dec 10, 1998 |
| Grant date | Nov 21, 2000 |
| Priority date | — |
| Expiry date | Dec 10, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D453/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds having Formula I ##STR1## or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising these compounds and to methods of inhibiting anglogenesis in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.